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Abstract:
Modifiable lifestyle factors influence the risk of developing many neurological diseases. These factors 
have been extensively linked with blood-based genome-wide DNA methylation (DNAm), but it is 
unclear if the signatures from blood translate to the target tissue of interest - the brain. To investigate 
this, we apply blood-derived epigenetic predictors of four lifestyle traits to genome-wide DNAm from 
five post-mortem brain regions and the last blood sample prior to death in 14 individuals in the 
Lothian Birth Cohort 1936 (LBC1936). Using these matched samples, we found that correlations 
between blood and brain DNAm scores for smoking, high-density lipoprotein cholesterol, alcohol and 
body mass index were highly variable across brain regions. Smoking scores in the dorsolateral 
prefrontal cortex had the strongest correlations with smoking scores in blood (r = 0.5, n=14, P = 0.07) 
and smoking behaviour (r =0.56, n=9, P = 0.12). This was also the brain region which exhibited the 
largest correlations for DNAm at site cg05575921 - the single strongest correlate of smoking in blood 
- in relation to blood (r =0.61, n=14, P = 0.02) and smoking behaviour (r =-0.65, n=9, P = 0.06). This 
suggested a particular vulnerability to smoking-related differential methylation in this region. Our 
work contributes to understanding how lifestyle factors affect the brain and suggests that lifestyle-
related DNAm is likely to be both brain region dependent and in many cases poorly proxied for by 
blood. Though these pilot data provide a rarely-available opportunity for the comparison of 
methylation patterns across multiple brain regions and the blood, due to the limited sample size 
available our results must be considered as preliminary and should therefore be used as a basis for 
further investigation.
Keywords:
Epigenetics, lifestyle, methylation, smoking
Abbreviations:
BA17 Brodmann’s area 17; BA46 Brodmann’s area 46; BA24 Brodmann’s area 24; BA35 
Brodmann’s area 35; BA20/21 Brodmann’s area 20/21; BMI Body mass index; CpG cytosine-guanine 
dinucleotide; DNAm DNA methylation; HDL High-density lipoprotein; LBC1936 Lothian Birth 
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Introduction
DNA methylation (DNAm) is one route by which modifications to the genome can occur and 
typically involves the addition of a methyl group to a cytosine residue on CG dinucleotides (CpGs).1 
Lifestyle traits such as smoking, alcohol intake and body mass index (BMI), as well as high-density 
lipoprotein (HDL) cholesterol levels are known to associate with differential blood DNAm at CpG 
sites across the genome. 2–8 These lifestyle factors are associated with a range of brain health 
outcomes and neurological diseases,9–14 in addition to brain morphology differences.15–18 Whereas the 
DNAm differences are likely to be a consequence, as opposed to cause, of lifestyle traits, it is 
unknown if these patterns are consistent across the blood and brain. Previous work suggests that blood 
is unlikely to reflect brain reliably for all CpGs, but that some sites more closely reflect brain DNAm 
than others.19–21 Given that the brain is the critical organ of interest for the pathology of neurological 
diseases, characterising the signature of DNAm resulting from lifestyle exposures in brain, as well as 
the extent to which blood DNAm can proxy for this is therefore paramount.
Blood-based DNAm predictors have been previously shown to explain 60% of the variance in 
self-reported smoking patterns and ~12% of the variance in the alcohol, smoking, and BMI when 
projected into blood DNAm.22 We therefore hypothesised that differential methylation patterns at the 
CpG sites associated with lifestyle traits in these blood predictors would be present across the 
corresponding sites in the brain. To test this, we applied the described out-of-sample blood-based 
predictors from our previous work22 to a pilot dataset consisting of matched blood and brain samples 
in 14 individuals from the Lothian Birth Cohort 1936 (LBC1936). We profiled four traits: HDL, BMI, 
alcohol and smoking. The most recent DNAm measure in blood taken prior to death was matched 
with genome-wide DNAm from post-mortem brain samples across five regions: Brodmann’s areas 
BA35 (hippocampus), BA46 (dorsolateral prefrontal cortex), BA24 (anterior cingulate cortex), 
BA20/21 (inferior temporal cortex) and BA17 (primary visual cortex). 
We first assessed the correspondence between the scores derived from blood-based lifestyle 
predictors between the blood and brain, to characterise how well circulating DNAm measures of 
lifestyle traits may translate to the brain.  We then compared the associations between the predictor 
scores and the corresponding self-reported or clinically assessed data available for each lifestyle trait. 
DNAm at a single CpG (cg05575921 in the AHRR gene; the strongest CpG correlate of smoking in 
blood which is hypomethylated in response to smoking)23,24 was also profiled in each of these 
analyses. This site is a key component of the smoking predictor and we hypothesised that the same 
hypomethylation observed in blood would also be evident in the brain. The relationship between 
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LBC1936 group to illustrate how representative the 14 individuals are of a larger reference group. The 
brain regions and study design are presented in Fig. 1.
Methods
The Lothian Birth Cohort 1936
The Lothian Birth Cohort 1936 (LBC1936, N=1,091) is a longitudinal study of healthy ageing in 
individuals who reside in Scotland.25,26 Participants completed a childhood intelligence test at age 11 
years in 1947 and were then recruited for this cohort at the mean age of 70 years. They have been 
followed up approximately every 3-4 years (currently at the 6th wave), collecting a series of cognitive, 
physical, clinical and social data, along with blood donations that have been used for genetic, 
epigenetic, and proteomic measurement. Approximately 15% of individuals in the LBC1936 have 
consented to post-mortem tissue collection. To date, brain samples from 14 individuals are available 
and were therefore selected as the brain bank group (n=14) for the present study. 
Participant consent
Written informed consent was obtained from all participants. Ethical permission for the LBC1936 was 
obtained from the Multi-Centre for Scotland (MREC/01/0/56), Lothian (LREC/2003/2/29) and 
Scotland A (07/MRE00/58) Research Ethics Committees. Use of human tissue for post-mortem 
studies has been reviewed and approved by the Edinburgh Brain Bank ethics committee and the 
ACCORD medical research ethics committee, AMREC (ACCORD is the Academic and Clinical 
Central Office for Research and Development, a joint office of the University of Edinburgh and NHS 
Lothian, ethical approval number 15-HV-016). Human tissue from the Edinburgh brain bank was used 
under the research ethics committee (REC) approval (16/ES/0084. All experimental methods were in 
accordance with the Helsinki declaration.
Blood DNAm in the Lothian Birth Cohort 1936
DNA from whole blood at 485,512 CpG sites was assessed using the Illumina Human Methylation 
450K array at the Edinburgh Clinical Research Facility. The full details of the processing steps have 
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internal controls. Following background correction, manual inspection permitted removal of low 
quality samples presenting issues relating to bisulphite conversion, staining signal, inadequate 
hybridisation or nucleotide extension. Quality control analyses were performed to remove probes with 
low detection rate <95% at P<0.01. Samples with a low call rate (samples with <450,000 probes 
detected at p-values of less than 0.01) were also eliminated. Furthermore, samples were removed if 
they had a poor match between genotype and SNP control probes, or incorrect DNA methylation-
predicted sex. There were a total of 450,276 probes which remained. Investigators were blinded to 
participant information when assessing DNAm to reduce potential sources of bias.
Blood DNAm was available for up to 4 waves, measured over a 10-year period. The most recent 
blood sample prior to death was selected and self-report and clinical information was also taken from 
the most recent wave for which it was available. The most recent blood measurement was performed 
at wave 3 in seven individuals and wave 4 in the remaining seven, with a mean time between blood 
sampling and death of 3.2 years (SD 1.6) in the wave 3 group and 1.6 years (SD 0.94) in the wave 4 
group (Supplementary Table 1). In the 14 individuals, the mean age at blood sampling was 77.9 (SD 
1.7) and the mean age at death was 80.3 (SD 1.6). The blood DNAm reference group (n=499) was 
taken from wave 4 of the LBC1936 and the mean age at sampling was 79.3 years (SD 0.62). Lifestyle 
trait information and blood DNAm were recorded in a consistent way across both the brain bank and 
reference groups.
Brain DNAm processing in the Lothian Birth Cohort 1936
Brain tissue samples were received from the Edinburgh Brain Bank. Regions of the brain were 
dissected after brains were removed and cut coronally into slices, as per previous methodology.29 
Samples from regions BA46 (dorsolateral prefrontal cortex), BA17 (primary visual cortex), BA24 
(anterior cingulate cortex), BA20-21 (ventral (20) and lateral (21) inferior temporal cortex) and BA35 
(hippocampus) were taken from the cortex and snap frozen. A tissue selection of ~25 mg was 
processed for DNA extraction, which was done using the DNeasy kit (Qiagen). DNAm was measured 
at the Edinburgh Clinical Research Facility using Illumina MethylationEPIC BeadChips. Quality 
control steps were then performed: the wateRmelon pfilter() function removed samples in which >1% 
of probes had a detection p-value of >0.05, probes with a beadcount of <3 in >5% of samples, and 
probes with >1% of samples reaching a detection p-value of >0.05. Additional SNP probes and cross-
hybridising probes on X and Y chromosomes were removed.30 If a discordance between the 
methylation-predicted sex and recorded sex was identified samples were also removed. Performance 
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ranking method.31 The normalised data had a total of 69 samples (14 individuals, across 5 regions, 
with 1 hippocampal sample unavailable) and 807,163 probes. DNAm beta values were used in all 
analyses. Investigators were blinded to participant information when assessing DNAm.
Lifestyle trait information in the Lothian Birth Cohort 1936
Lifestyle trait phenotype measurements were as follows: self-reported smoking status (0=never 
smoked, 1=former smoker, 2=current smoker); alcohol consumption in a usual week (converted into 
units); BMI (defined as the ratio of weight in kg divided by height in m2) and HDL cholesterol 
(measured in mmol/L). Pack years smoked was calculated by multiplying the number of packs of 
cigarettes smoked per day by the number of years the individual had smoked for, divided by 20 
(cigarettes per pack). If a person reported having never smoked, their pack years was recorded as 0 
and this was done for both the reference and brain bank groups. Of the reference group, 37 people had 
pack years available, 193 did not have information available and the remaining 269 indicated that they 
were never smokers. Five individuals were excluded from the pack years trait in the brain bank group 
as they did not have information on the number of packs smoked per day, which is why a smaller 
subset were used for analysis of this trait (n=9). One individual in the brain bank group did not have a 
starting age for smoking; however, the mean of the group starting age was imputed (16 years old). 
Any other unknown trait information from the reference group was not used. Mortality data were 
obtained through data linkage to the National Health Service Central Register, provided by the 
General Register Office for Scotland (now National Records of Scotland) and were correct as of July 
2020. 
DNAm signature predictor scores for lifestyle traits 
CpG predictor weights for complex traits were generated and validated through a pipeline described 
previously.22 Briefly, LASSO penalised regression was used to identify a linear combination of CpG 
sites with DNAm levels that were associated with lifestyle traits. The coefficients/weights generated 
for the CpG sites were based on whole-blood derived samples from 5,087 individuals (mean age = 49, 
SD = 14) in the Generation Scotland cohort.32,33 Though Scotland has an historic and sustained high 
prevalence of unhealthy lifestyle behaviours such as smoking and alcohol consumption, with a large 
proportion of the current population either overweight or obese,34,35 cohort profiling has found both 
the Generation Scotland and Lothian Birth Cohorts to be healthier and of higher socioeconomic status 
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Here, the described CpG weights for each trait (taken from McCartney et al.22 Additional file 1: 
Tables S1-3 and Table S6) were applied to DNAm at the same CpG sites in LBC1936 individuals and 
summed to generate predictor scores for smoking, HDL, BMI and alcohol for each individual. 
Lifestyle trait scores were generated using DNAm in the blood and five brain regions in the brain 
bank group (n=14) and the blood DNAm which was available in the reference group (n=499). Blood 
and brain DNAm samples were restricted to sites included on the Illumina Human Methylation 450K 
array, to ensure comparability across samples. Over 95% of CpG sites in the predictors were available 
in both the blood and brain DNAm for each lifestyle trait score.
Statistical analyses
First, Pearson correlations were applied to measure the correspondence between the methylation 
predictors in the blood and brain. These correlated the lifestyle predictor scores - generated from the 
application of blood-derived CpG predictor weights - between blood and brain, as well as the DNAm 
measurements at site cg05575921 between the blood and brain. Second, Pearson correlations were 
used to measure the relationships between brain and blood DNAm measures of lifestyle traits and the 
respective lifestyle trait information. Units of alcohol consumed weekly, BMI, HDL cholesterol from 
blood and both smoking status and pack years smoked were included as traits and correlated with the 
DNAm-based lifestyle predictor scores. Smoking information was also correlated with DNAm at site 
cg05575921. These lifestyle trait correlations were also performed for the blood-based predictor 
scores and cg05575921 measurements in the reference group from wave 4 of the LBC1936. 
As a sensitivity analysis, Spearman correlations were conducted for every association tested in the 
described Pearson correlations. Inter-region Spearman correlations were also performed for the blood-
derived lifestyle predictor scores applied to brain and for the cg05575921 DNAm measure across the 
five regions. Though covariate information was available on the proportion of neurons in the brain, 
the brain weight, brain pH and most-mortem interval, power calculations suggested that linear mixed 
effects regression analyses in the sample size of 14 individuals were unlikely to be sufficiently 
powered to detect significant effects (Supplementary Table 2). For this reason, no further statistical 
testing was performed. Correlations were conducted using the Hmisc library (Version 4.4-0).37 Inter-
region correlation heatmaps were produced using the ggcorrplot library (Version 0.1.3)38 and 
correlation plots were produced using the corrplot library (Version 0.84).39 All analyses were 
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LBC1936 data are available on request from the Lothian Birth Cohort Study, University of Edinburgh 
(simon.cox@ed.ac.uk). LBC1936 data are not publicly available due to them containing information 
that could compromise participant consent and confidentiality.
Code availability 
All R code used in this study is available with open access at the following Gitlab repository: 
https://gitlab.com/dannigadd/blood-brain-lifestyle-traits. The predictor weights used in our study and 
the original code used to generate them (McCartney et al.22) can also be found at this location.
Results
Cohort assessment
Summary information for the 14 individuals from the LBC1936 brain bank subset and the reference 
group (up to n=499) is presented in Table 1. The brain bank subset had a higher proportion of males 
(64%) than the reference group (50%). Age at death in the brain donor group ranged from 77.6 to 83.0 
years and the mean age of the reference group was well matched to this group (77.9 vs 79.3, 
respectively). The majority of the 14 individuals within the brain bank subset either had been or were 
still smokers (86%) at the time of death, which was a higher proportion than in the reference group 
(46%). Most of the 14 individuals (86%) had high HDL cholesterol (> 1 mmol/L), drank alcohol 
weekly (92%) and had mean BMI of 25.5 kg/m2. Five of the individuals did not have smoking pack 
years data recorded.
Correlation between blood and brain measures
Blood-derived epigenetic predictors for lifestyle traits were applied to the matched blood and brain 
DNAm samples in the brain bank group to generate lifestyle trait scores. DNAm at the smoking-
associated CpG site cg05575921 was also considered. The variability across brain regions in the 
magnitude of correlations between DNAm predictor scores and DNAm at site cg05575921 are 
illustrated in Supplementary Fig. 1. The correlations between both the blood and brain lifestyle 
scores and the blood and brain measures of cg05575921 were regionally variable (Fig. 2). The 
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=0.61, n=14, P = 0.02) followed by BA17 (r =0.39, n=14, P = 0.16). Blood smoking scores were most 
highly correlated with the BA46 region scores for smoking (r =0.5, n=14, P = 0.07), with weaker 
associations observed for BA24 (r =0.29, n=14, P = 0.31) and BA35 (r =0.36, n=13, P = 0.23). BMI 
scores were negatively correlated in regions BA46 (r =-0.72, n=14, P = 0.004) and BA35 (r =-0.46, 
n=14, P = 0.12), suggesting that methylation patterns related to BMI were divergent across blood and 
brain. The HDL scores were moderately-correlated between the blood and region BA20/21 (r =0.55, 
n=14, P = 0.04), with weaker correlations observed for regions BA24 (r =0.38, n=14, P = 0.18) and 
BA35 (r =-0.32, n=13, P = 0.29). Blood alcohol scores were most highly correlated with BA24 (r 
=0.35, n=14, P = 0.22) and with BA46 (r =0.25, n=14, P = 0.38) alcohol scores. A sensitivity analysis 
suggested that the strongest correlations were consistent across Pearson and Spearman methods. The 
correlation coefficients and p-values are presented for both analyses in Supplementary Table 3.
Correlation of blood and brain measures with lifestyle traits
The lifestyle trait scores generated by applying blood-derived epigenetic predictors to brain and blood 
samples and the DNAm measures at site cg05575921 were then correlated with clinical and self-
reported lifestyle phenotypes (Fig. 3). 
As expected, in the reference cohort we observed hypomethylation in blood DNAm levels of 
cg05575921 associated with pack years smoked (r =-0.31, n=306, P = 4.7x10-8). This trend was 
mirrored by the negative association found for blood DNAm at cg05575921 in the brain bank subset 
(r =-0.55, n=9, P = 0.11). Similar patterns were observed in some but not all brain regions. The 
strongest association for cg05575921 in brain with pack years was found for region BA46 (r =-0.65, 
n=9, P = 0.06), followed by a weaker correlation in BA35 (r =-0.22, n=8, P = 0.59). BA20/21 had an 
opposite trend to that expected in blood (r =0.2, n=9, P = 0.61). Methylation in all other brain regions 
showed much weaker associations with the pack years phenotype (|r| ≤ 0.1).
Regarding the lifestyle predictor scores, all trait scores in the blood samples from the brain bank 
subset were reflective of the wider reference cohort in terms of direction and approximate magnitude 
(|r| between 0.35 and 0.65), except BMI for which the brain bank group (r =-0.14, n=14, P = 0.68) 
was not representative of the reference group (r =0.41, n=498, P < 0.05). As with the results for 
cg05575921, BA46 was the region for which smoking scores were most highly correlated with pack 
years smoked (r =0.56, n=9, P = 0.12). To a lesser extent BA17 (r =0.22, n=9, P = 0.56) and BA35 (r 
=0.24, n=8, P = 0.56) smoking scores were also correlated with pack years. HDL brain scores 
correlated with HDL trait information strongly in BA17 (r =0.62, n=14, P = 0.02), whereas BA35 (r 
=0.21, n=14, P = 0.49) had a weaker association and a negative trend was observed for BA46 (r =-0.4, 
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0.04) and BA20/21 (r =-0.41, n=14, P = 0.15), in the opposite direction to that found in blood. BMI 
signature scores in BA17 were negatively correlated with BMI information (r =-0.3, n=14, P = 0.3) in 
a trend opposite to the LBC reference group and BA20/21 also had a positive correlation with BMI (r 
=0.27, n=14, P = 0.35). The remaining regions did not show any notable correlations with BMI trait 
information (|r| ≤ 0.1). A sensitivity analysis comparing Pearson and Spearman methods found that, 
though there was variability across the methods, the top associations were consistent (Supplementary 
Table 4). Correlations between smoking measures and smoking status are also available in this file.
Discussion
Through the application of blood-derived epigenetic predictors of four lifestyle traits to 
whole-genome DNA methylation in matched blood and brain samples, we uncover regional 
variability in how well blood-derived scores may be able to proxy for brain-based scores. Though our 
results highlight disparities between the blood and the brain, we did find evidence to suggest that the 
blood-derived predictors of lifestyle traits may translate to specific regions. The dorsolateral 
prefrontal cortex (BA46) was identified as a region of interest for the smoking trait and showed 
relationships in our analyses using the epigenetic predictor of smoking and the CpG site cg05575921 - 
the single strongest known correlate of smoking across the epigenome. We present these preliminary 
findings as a contribution to the ongoing, important question of how circulating DNAm measures are 
able to reflect methylation in brain tissue.
The pilot dataset used in this study provided a rarely-accessible resource to compare genome-
wide methylation specific to each of the five brain regions against matched blood methylation in the 
same individuals. Given that the generation of epigenetic predictors requires large training datasets, it 
was not feasible to generate lifestyle predictors derived from brain DNAm in this study, but we 
hypothesised that CpG sites from the blood predictors of lifestyle traits would be concordant in their 
methylation patterns in the brain. We tested this by applying blood-derived CpG predictor weights to 
the matched blood and brain samples. This context is central to the interpretation of our results, which 
suggest that lifestyle-related methylation in some brain regions is more highly correlated with blood 
than others. The variability we found across brain regions may be due to two possibilities: 1) lifestyle 
traits may have a stronger influence on DNAm in the regions which were well-correlated, or 2) poorly 
correlated regions may have CpGs influenced by lifestyle traits which are unique to the brain and 
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Previous studies have found that many sites in the genome are poorly correlated between the 
blood and brain with further variability across brain regions.19–21 The cg05575921 site has been shown 
to correlate between blood and adipose tissue,41 suggesting that it may have a discernible trace across 
circulating measures and tissues; however, in most brain regions we did not observe strong 
correlations at this site both in relation to blood or smoking traits. Generally, there were weak 
correlations between the lifestyle predictors across blood and brain samples and in relation to lifestyle 
traits for many regions. Though the effects of lifestyle on brain DNAm directly are relatively 
unknown, in the LBC1936 sample, the blood-based DNAm predictor for smoking used in the present 
study has been shown to associate with brain morphology differences.16 There is also evidence linking 
in utero exposure to smoking and alcohol use disorders to brain DNAm alterations42,43. Blood lipids 
have also been causally associated with DNAm differences in circulating cells,44 though it is unknown 
whether this is true of lipids and brain DNAm. Taken together, these studies suggest that our findings 
may be due to possibility (2), that there could be CpG sites related to lifestyle traits which are unique 
to the brain and may not be captured in the present study. 
The dorsolateral prefrontal cortex (BA46) smoking predictor score and methylation at site 
cg05575921 were well-correlated with both the equivalent measures in blood and smoking trait 
information. A previous study found that of four regions, DNAm at cg05575921 in blood was most 
highly correlated with cg05575921 in the prefrontal cortex (r=0.28, P=0.02) in matched samples in 74 
individuals.20 Though this correlation is somewhat weaker than that observed in our study, it suggests 
that possibility (1) may be correct; there may be a particularly strong influence of smoking on 
differential DNAm in regions such as BA46. This possibility is further supported by studies that have 
pinpointed the frontal cortex as a region that is particularly vulnerable to the effects of smoking on 
brain morphology.15,45 One of the discussed studies was able to show that smoking had unique 
statistical contributions to brain morphology when modelling against many other vascular risk factors 
(VRFs) in a large population (N=9,722)45; these findings indicate that there some brain areas may be 
more susceptible to smoking. As VRFs (such as smoking) associate with various adverse outcomes 
including cognitive ageing and dementia,46–49 areas such as BA46 may be more susceptible to ageing 
and effects that underpin cognitive function, as they show the strongest VRF-related coupling in blood 
and brain. A larger sample with more detailed regional sampling across the brain will be required to 
investigate DNAm differences in relation to this. 
Though our brain bank sample was particularly enriched for smoking and alcohols traits, we 
anticipate our results generalising to similar populations due to the representative nature of the large 
healthy ageing cohort used to train lifestyle predictors.36 The weights that we used for BMI and 
smoking have also been projected into an independent cohort.50 An important caveat is the relatively 
homogeneous Scottish ancestries of both cohorts in this study, which may limit translation of our 
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cohorts, as they are considered to be of higher socioeconomic status than the general population.26,36 
The LBC1936 group were born in 1936 and there are socioeconomic and cultural trends in their 
lifestyles that must be taken into consideration; many may have worked in factories or in shipbuilding 
yards, exposing them to high levels of respiratory pollutants and poorer socioeconomic status in this 
era was related to behaviours such as smoking.51,52 Associations between childhood intelligence and a 
range of comorbidities in this group have also been shown to be partially attenuated by smoking.51 
However, we anticipate that the generally poor correlations between lifestyle trait predictors which we 
observe across the blood and brain would also be seen in other cohorts with reduced exposures to the 
lifestyle factors studied here.
There are a number of limitations to our study. First, there were only 14 individuals with 
matched samples in the LBC1936 brain bank. As discussed, the lack of brain DNAm samples meant 
that it was not possible to create lifestyle predictors in brain tissue. Recent work has generated 
predictors for ageing in cortical samples, providing evidence that, though imperfect, there is a 
concordance between predictors generated in blood and brain.53 Future work should seek to determine 
if this is the case for lifestyle predictors. The limited sample size also meant that though we had 
information on covariates such as the post-mortem interval between death and brain DNAm sampling, 
regression analyses were not feasible due to insufficient power. Though confounders may have 
influenced our results, the effect of post-mortem interval is still debated.54,55 Second, the blood-based 
BMI DNAm signatures of the 14 individuals were not reflective of the wider reference group and are 
therefore limited in their interpretability. Third, differences have been observed in DNAm levels from 
the same blood samples when measured by different arrays.56 Here, the EPIC array was used to 
generate DNAm measures in both the Generation Scotland cohort used to train predictor weights 
(after being subset to sites overlapping with the 450K array) and in the brain DNAm subset of 14 
individuals. The EPIC-derived DNAm predictors correlated well with the lifestyle traits when applied 
to the blood-based LBC samples, which were all assessed on the 450K array. Fourth, many current or 
former smokers had not reported pack years information and there was variability in the strength of 
correlations across smoking phenotypes. Though trends for the smoking status trait were generally 
weaker than those observed for pack years, this difference may be reflective of the longitudinal nature 
of smoking that pack years captures. Finally, whereas all participants were free from 
neurodegenerative conditions at the study recruitment at age 70, the absence of clinical data on 
subsequent diagnoses means that we cannot rule out the possibility that these results are partly driven 
by disease-specific DNAm profiles in the brain. Several studies have found differential DNAm at 
regions such as the hippocampus in those with Alzheimer’s disease pathology, suggesting that DNAm 
alterations may result from the pathological changes seen before symptoms arise.57,58 Growing sample 
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Conclusion
In this study, we characterise variability in how well blood-derived epigenetic measures of lifestyle 
traits correlate when applied across a rarely-available pilot dataset consisting of matched blood and 
brain samples. We find variability in the alignment between blood and brain lifestyle predictor scores 
across brain regions, with the most notable relationships found between the dorsolateral prefrontal 
cortex (BA46) and smoking-related measures. Though our work relies on the application of blood-
based signatures of lifestyle traits to brain tissue and is limited by low sample size, it nonetheless 
provides a preliminary insight into whether circulating DNAm proxies may reflect the epigenetic 
effects of lifestyle traits in the brain. This is critical given the known associations between modifiable 
lifestyle factors with both neurological disease risk and brain health outcomes.
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Study group Reference group 
Characteristic
N=14 N=499
 n (%) mean (sd) n (%) mean (sd)
Sex     
 Female 5 (36%) 248 (50%)









Smoking status     
Current 5 (36%) 19 (4%)





Pack years smoked  53 (40)  4 (15)
Unknown  5  193
Alcohol units per week  14 (15)  11 (11)
Unknown    141
Body mass index (kg/m2)  25.5 (5.1)  27.3 (4.5)
Unknown    1
HDL cholesterol (mmol/L)  1.49 (0.4)  1.48 (0.4)
Unknown    16
Brain pH  6.1 (0.2)   
Time to death (years)  2.4 (1.5)   
Age at death (years)  80.3 (1.6)   




   
Table 1. Summary information for the brain bank subset (n=14) and reference cohort 
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Figure Legends
Fig. 1. The application of blood-derived epigenetic predictors of four lifestyle traits to matched blood and brain 
DNA methylation samples in 14 individuals. (A) The five brain regions examined in 14 individuals with matched 
DNAm across brain regions and the last blood sample taken prior to death. (B) Epigenetic predictors of HDL, BMI, 
alcohol and smoking generated in 5087 out-of-sample individuals (McCartney et al.22) were applied to matched 
genome-wide blood and brain DNAm. The cg05575921 site in the AHRR gene locus was also measured across 
matched blood and brain samples. Analyses investigated the correlation between blood and brain measures and the 
correlation between the measures and respective lifestyle trait phenotypes relevant in each case. Figure created with 
BioRender.com.
Fig. 2. Correlations for (A) site cg05575921 (dark blue) and blood-derived lifestyle trait predictor scores for (B) 
smoking, (C) HDL, (D) alcohol and (E) BMI traits applied to the blood and brain (light blue). Relationships 
between brain DNAm and blood DNAm are shown for each brain region and measure. Each point represents one 
individual. Pearson correlation coefficients are annotated in each case. All individuals had both blood and brain 
samples available (n=14), apart from one individual for which no BA35 hippocampal sample was available (n=13). 
The solid blue line represents the linear regression slope; shaded areas represent 95% confidence intervals. 
Fig. 3. Lifestyle trait correlations with the blood DNAm measures from the reference group (up to n=499) and 
the blood and brain measures for the brain bank group (n=14). Correlations for blood measures are shown in red, 
with cg05575921 DNAm in dark blue and lifestyle trait scores generated from the application of blood-derived 
lifestyle predictors to brain in light blue. A, DNAm at site cg05575921 is correlated with pack years smoked for the 
reference (n=306) and brain bank (n=9) groups. Correlations are then provided for each group between lifestyle trait 
scores for (B) smoking, (C) HDL, (D) alcohol and (E) BMI, against relevant lifestyle trait information. HDL is 
measured in mmol/L. Alcohol is measured in average units per week. Each point represents one individual. Pearson 
correlation coefficients are annotated in each case. All individuals had both blood and brain samples available (n=14), 
apart from one individual for which no BA35 hippocampal sample was available. The solid blue line represents the 
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Fig. 1. The application of blood-derived epigenetic predictors of four lifestyle traits to matched blood and 
brain DNA methylation samples in 14 individuals. (A) The five brain regions examined in 14 individuals with 
matched DNAm across brain regions and the last blood sample taken prior to death. (B) Epigenetic 
predictors of HDL, BMI, alcohol and smoking generated in 5087 out-of-sample individuals (McCartney et al., 
2018) were applied to matched genome-wide blood and brain DNAm. The cg05575921 site in the AHRR 
gene locus was also measured across matched blood and brain samples. Analyses investigated the 
correlation between blood and brain measures and the correlation between the measures and respective 
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Fig. 2. Correlations for (A) site cg05575921 (dark blue) and blood-derived lifestyle trait predictor scores for 
(B) smoking, (C) HDL, (D) alcohol and (E) BMI traits applied to the blood and brain (light blue). 
Relationships between brain DNAm and blood DNAm are shown for each brain region and measure. Each 
point represents one individual. Pearson correlation coefficients are annotated in each case. All individuals 
had both blood and brain samples available (n=14), apart from one individual for which no BA35 
hippocampal sample was available (n=13). The solid blue line represents the linear regression slope; shaded 
areas represent 95% confidence intervals. 
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Fig. 3. Lifestyle trait correlations with the blood DNAm measures from the reference group (up to n=499) 
and the blood and brain measures for the brain bank group (n=14). Correlations for blood measures are 
shown in red, with cg05575921 DNAm in dark blue and lifestyle trait scores generated from the application 
of blood-derived lifestyle predictors to brain in light blue. A, DNAm at site cg05575921 is correlated with 
pack years smoked for the reference (n=306) and brain bank (n=9) groups. Correlations are then provided 
for each group between lifestyle trait scores for (B) smoking, (C) HDL, (D) alcohol and (E) BMI, against 
relevant lifestyle trait information. HDL is measured in mmol/L. Alcohol is measured in average units per 
week. Each point represents one individual. Pearson correlation coefficients are annotated in each case. All 
individuals had both blood and brain samples available (n=14), apart from one individual for which no BA35 
hippocampal sample was available. The solid blue line represents the linear regression slope; shaded areas 
represent 95% confidence intervals. 
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Abbreviated summary:  Gadd et al. apply blood-derived epigenetic signatures of lifestyle traits to matched blood and 
brain samples, uncovering variability in how well blood translates across brain regions and a relationship between 
smoking and the prefrontal cortex. These preliminary results contribute to understanding how lifestyle-related DNA 
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